EcoDrugPlus

Ribosomal Protein L8

Ensembl ID : ENSLACG00000006824
Gene Symbol: RPL8
4 Cross references
122 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSLACG00000006034
Gene Symbol: RPL9
4 Cross references
511 Possible Orthologues:

Ribosomal Protein S10

Ensembl ID : ENSLACG00000017219
Gene Symbol: RPS10
4 Cross references
382 Possible Orthologues:

Ribosomal Protein S11

Ensembl ID : ENSLACG00000001903
Gene Symbol: RPS11
4 Cross references
279 Possible Orthologues:

Ribosomal Protein S12

Ensembl ID : ENSLACG00000003936
Gene Symbol: RPS12
4 Cross references
176 Possible Orthologues:

Ribosomal Protein S13

Ensembl ID : ENSLACG00000017174
Gene Symbol: RPS13
4 Cross references
64 Possible Orthologues:

Ribosomal Protein S13

Ensembl ID : ENSLACG00000017012
Gene Symbol: RPS13
1 Cross references
293 Possible Orthologues:

Ribosomal Protein S14

Ensembl ID : ENSLACG00000016164
Gene Symbol: RPS14
4 Cross references
116 Possible Orthologues:

Ribosomal Protein S14

Ensembl ID : ENSLACG00000004342
Gene Symbol: RPS14
1 Cross references
193 Possible Orthologues:

Ribosomal Protein S15

Ensembl ID : ENSLACG00000009571
Gene Symbol: RPS15
4 Cross references
336 Possible Orthologues:

Ribosomal Protein S15a

Ensembl ID : ENSLACG00000011476
Gene Symbol: RPS15A
4 Cross references
514 Possible Orthologues:

Ribosomal Protein S16

Ensembl ID : ENSLACG00000015556
Gene Symbol: RPS16
4 Cross references
277 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).